Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) EBT (2016 - 2025)

Historic EBT for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $109.2 million.

  • Qiagen's EBT fell 1325.6% to $109.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $490.3 million, marking a year-over-year increase of 30468.6%. This contributed to the annual value of $490.3 million for FY2025, which is 30468.6% up from last year.
  • Per Qiagen's latest filing, its EBT stood at $109.2 million for Q4 2025, which was down 1325.6% from $134.7 million recorded in Q3 2025.
  • Qiagen's EBT's 5-year high stood at $195.5 million during Q1 2022, with a 5-year trough of -$223.5 million in Q2 2024.
  • Over the past 5 years, Qiagen's median EBT value was $117.7 million (recorded in 2023), while the average stood at $107.4 million.
  • As far as peak fluctuations go, Qiagen's EBT soared by 24341.34% in 2021, and later tumbled by 31839.3% in 2024.
  • Qiagen's EBT (Quarter) stood at $165.4 million in 2021, then crashed by 36.0% to $105.8 million in 2022, then grew by 12.32% to $118.9 million in 2023, then grew by 5.87% to $125.9 million in 2024, then fell by 13.26% to $109.2 million in 2025.
  • Its EBT stands at $109.2 million for Q4 2025, versus $134.7 million for Q3 2025 and $126.8 million for Q2 2025.